Skip to content

Comparison between oral mifepristone and intracervical dinoprostone gel for initiating labour

Comparison between oral mifepristone and intracervical dinoprostone gel for cervical ripening and induction of labour - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/108626
Enrollment
130
Registered
2026-04-20
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O09- Supervision of high risk pregnancy

Interventions

Intervention1: Oral Mifepristone: Initial PV examination to record Bishop score (less than 6) followed by administration of 200 mg oral mifepristone tablet. Reassessment of bishop score after 24 hours

Sponsors

Postgraduate Institute of Medical Education and Research, Chandigarh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age 18 to 45 Singleton pregnancy Cephalic pregnancy Term 37 to 40 weeks Bishop score less than 6 No contraindications to vaginal delivery or IOL Reactive Non stress test Willing to participate in study Signed informed consent

Exclusion criteria

Exclusion criteria: Previously scarred uterus seen in LSCS, Classical cesarean, Hysterectomy, Myomectomy Premature rupture of membranes, Chorioamniitis Cephalopelvic disproportion Hypersensitivity to study drugs Non reassuring fetal status, severe oligohydramnios, APH Multipla pregnancy Grand multipara Medical disorders like uncontrolled diabetes, uncontrolled hypertension, impaired genetic and renal function, cardiac steroids, glaucoma Patient on steroids patient with known, Gross congenitaj malformation refusal of conssrnt

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy of Mifepristone for cervical ripening and induction of labour in terms of Mean change of Bishop score after 24 hours and induction to delivery interval (in hours)Timepoint: 24 hours

Secondary

MeasureTime frame
A. To study the need of addtional agents of cervical ripening & IOL in group receiving Mifepristone B. To compare outcomes of cervical ripening & IOL between both groups in terms of 1. Need for oxytocin augmentation 2. Rate of failed induction (Number, mode of delivery, outcomes of pregnancy) 3. Rate of cesarean section & indication 4. Intrapartum maternal & fetal events (fetal distress, non progress of labour, tachysystole, uterine rupture, instrumental delivery, PPH) 5. Fetal outcomes (APGAR, NICU admissions) 6. Failed inductions (Number, mode of delivery, outcomes of pregnancy) Timepoint: A. Additional agents required after 24 hours of Mifepristone till delivery B. 1. Need for oxytocin 24 hours after Mifepristone till delivery in intervention group & from after last dose of gel till delivery in comparison group 2. Failure of IOL after 24 hours of mifepristone & 3 doses of gel in mifepristone group & Failure of induction after 3 doses of gel in dinoprostone group 3. After delivery 4. During delivery 5. from delivery to 24 hours after delivery

Countries

India

Contacts

Public ContactDr Anshika Jain

Postgraduate institute of medical education and research, Chandigarh

drseemachopra@yahoo.com9914209351

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026